Hologic DEXA scanner wins clearance
Bone densitometry firm Hologic has received regulatory clearance for its newest product, QDR-4500AAcclaim. Hologic, of Waltham, MA, introduced the dual-energy x-rayabsorptiometry (DEXA) system at last year's Radiological Societyof North America meeting
Bone densitometry firm Hologic has received regulatory clearance for its newest product, QDR-4500AAcclaim. Hologic, of Waltham, MA, introduced the dual-energy x-rayabsorptiometry (DEXA) system at last year's Radiological Societyof North America meeting (SCAN 12/28/94).
Hologic last month also released financial results for thefirst quarter of fiscal 1995 (end-December). The company posteda 33% increase in revenues, to $10.2 million, compared to $7.6million in the first quarter of 1994. Net income was $644,000for the most recent quarter, compared to $413,000 for the sameperiod last year.
New Collaboration Offers Promise of Automating Prior Authorizations in Radiology with AI
March 26th 2025In addition to a variety of tools to promote radiology workflow efficiencies, the integration of the Gravity AI tools into the PowerServer RIS platform may reduce time-consuming prior authorizations to minutes for completion.
The Reading Room Podcast: Current Perspectives on the Updated Appropriate Use Criteria for Brain PET
March 18th 2025In a new podcast, Satoshi Minoshima, M.D., Ph.D., and James Williams, Ph.D., share their insights on the recently updated appropriate use criteria for amyloid PET and tau PET in patients with mild cognitive impairment.
Predicting Diabetes on CT Scans: What New Research Reveals with Pancreatic Imaging Biomarkers
March 25th 2025Attenuation-based biomarkers on computed tomography (CT) scans demonstrated a 93 percent interclass correlation coefficient (ICC) agreement across three pancreatic segmentation algorithms for predicting diabetes, according to a study involving over 9,700 patients.
Can Photon-Counting CT be an Alternative to MRI for Assessing Liver Fat Fraction?
March 21st 2025Photon-counting CT fat fraction evaluation offered a maximum sensitivity of 81 percent for detecting steatosis and had a 91 percent ICC agreement with MRI proton density fat fraction assessment, according to new prospective research.
